Therapy News and Research

RSS

Loyola study to evaluate whether transcranial magnetic stimulation can help people with tinnitus

Loyola University Medical Center is studying whether a new form of non-invasive magnetic therapy can help people who suffer debilitating tinnitus (ringing in the ears).

19 Sep 2012

Women with early menopause more likely to develop coronary heart disease and stroke

Women who go into early menopause are twice as likely to suffer from coronary heart disease and stroke, new Johns Hopkins-led research suggests. The association holds true in patients from a variety of different ethnic backgrounds, the study found, and is independent of traditional cardiovascular disease risk factors, the scientists say.

19 Sep 2012

Bionic legs: an interview with Rob Cripe, SVP of Marketing from Tibion

The Bionic Leg is a wearable robotic trainer that is used on mobility impaired patients who need to relearn how to use their affected limb. It is used by clinicians as a tool that is designed to help strengthen stance, improve gait and enhance active motor learning.

19 Sep 2012

Music underlies the ability to acquire language

Contrary to the prevailing theories that music and language are cognitively separate or that music is a byproduct of language, theorists at Rice University's Shepherd School of Music and the University of Maryland, College Park (UMCP) advocate that music underlies the ability to acquire language.

19 Sep 2012

FDA Division of Neurology Products, CoLucid reach agreement for lasmiditan development strategy

CoLucid Pharmaceuticals, Inc., a privately held biopharmaceutical company, has reached agreement with the Food and Drug Administration's Division of Neurology Products concerning the development strategy for lasmiditan at a recently completed End of Phase 2 meeting.

19 Sep 2012

Researchers identify 21 proteins that specifically bind to ataxin-1

Misfolded proteins can cause various neurodegenerative diseases such as spinocerebellar ataxias (SCAs) or Huntington's disease, which are characterized by a progressive loss of neurons in the brain. Researchers of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, together with their colleagues of the Universit- Paris Diderot, Paris, France, have now identified 21 proteins that specifically bind to a protein called ataxin-1.

19 Sep 2012

Devon Medical Products receives PDAC approval for extriCARE 2400 system

Devon Medical Products, a global medical device manufacturer and distributor, today announced it has received approval from the Pricing, Data Analysis, and Coding (PDAC) contractor for its extriCARE 2400 Negative Pressure Wound Therapy (NPWT) pump and associated bandages and disposable canister.

19 Sep 2012

Alendronate decreases BMD loss in prostate cancer

Weekly administration of oral biphosphonate alendronate could reduce loss of bone mineral density in prostate cancer patients who start androgen-deprivation therapy, show study findings.

19 Sep 2012

Social threat reveals self-esteem mismatch in social anxiety disorder adolescents

Adolescents with social anxiety disorder have a marked discrepancy between implicit and explicit self-esteem following a social threat, such as being asked to give a speech, the results of a German study indicate.

19 Sep 2012

Daily use of inhaled steroid may not be essential in mild asthma patients

Individuals with mild-to-moderate asthma who use inhaled corticosteroids only when symptomatic can achieve the same level of symptom control as those who use the drug daily, study results show.

18 Sep 2012

Intensive rehabilitation may put off move to nursing facilities for elderly

Elderly, community-dwelling individuals who visit hospital with an acute illness are less likely to be transferred to skilled nursing facilities if they receive an intensified type of rehabilitation rather than usual rehabilitative care, report US researchers.

18 Sep 2012

‘Disappointing’ findings for spinal manipulative therapy

Spinal manipulative therapy for acute low-back pain appears to be no better than other existing therapies for reducing pain and improving functional status, show the findings of a Cochrane review.

18 Sep 2012

Abiraterone acetate confirmed to offer significant survival benefit to advanced prostate cancer patients

Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga®) offers a significant survival benefit to patients with castration-resistant prostate cancer, which is spreading to other parts of their body (known as metastatic prostate cancer).

18 Sep 2012

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Pfizer Inc. announced today that 14 abstracts for tofacitinib, an investigational oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA), will be presented at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2012 Annual Meeting, which is being held November 9-14 in Washington, D.C.

18 Sep 2012

Thalidomide effective in treating disabling cough among people with idiopathic pulmonary fibrosis

In the first clinical trial to demonstrate an effective treatment for constant, disabling cough among people with idiopathic pulmonary fibrosis (IPF), researchers at the Johns Hopkins University School of Medicine found that taking thalidomide significantly reduced the cough and improved quality of life.

18 Sep 2012

Power of taxane-based chemotherapy drugs may be potentially underestimated

The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.

18 Sep 2012

Apixaban offers minor added benefit for adult patients after hip replacement

The clot-inhibiting drug apixaban was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint.

18 Sep 2012

BACE2 enzyme could represent powerful new tool against Alzheimer's

An enzyme that could represent a powerful new tool for combating Alzheimer's disease has been discovered by researchers at Mayo Clinic in Florida. The enzyme - known as BACE2 - destroys beta-amyloid, a toxic protein fragment that litters the brains of patients who have the disease.

18 Sep 2012

Harris Health System celebrates completion of Smith Clinic

On Sept. 12, Harris Health System celebrated the completion of Smith Clinic, the system's first outpatient specialty facility. The new facility enhances and expands specialty care for patients formerly seen at hospital-based clinics located at Ben Taub Hospital.

18 Sep 2012

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received FDA clearance for a new molecular diagnostic test for Group A Streptococcus on the illumigene platform.

18 Sep 2012